Literature DB >> 21295129

In vitro anti-inflammatory and anti-cancer activities of Cuscuta reflexa Roxb.

V Suresh1, V Sruthi, B Padmaja, V V Asha.   

Abstract

AIM OF THE STUDY: To determine anti-inflammatory and anti-cancer activities of Cuscuta reflexa in cell lines (in vitro).
MATERIALS AND METHODS: Anti-inflammatory activity of the water extract was analysed in vitro using lipopolysaccharide (LPS) induced inflammatory reactions in murine macrophage cell line RAW264.7. The expression of COX-2 and TNF-α genes involved in inflammation was analysed by SQ RT-PCR. EMSA was conducted to analyse the influence of the extract on NF-κB signalling. Anti-cancer activity was analysed on Hep3B cells by MTT assay, DAPI staining, annexin V staining and SQ-RT PCR analysis of BAX, Bcl-2, p53 and survivin.
RESULTS: The extract down regulated LPS induced over expression of TNF-α and COX-2 in RAW264.7 cells; blocked NF-κB binding to its motifs and induced apoptosis in Hep3B cells as evidenced from MTT, DAPI staining and annexin V staining assays. The extract up regulated pro-apoptotic factors BAX and p53, and down regulated anti-apoptotic factors Bcl-2 and survivin.
CONCLUSIONS: The study showed that Cuscuta reflexa inhibits LPS induced inflammatory responses in RAW264.7 cells through interplay of TNF-α, COX-2 and NF-κB signalling. It induced apoptosis in Hep3B cells through the up regulation of p53, BAX and down regulation of Bcl-2 and survivin.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295129     DOI: 10.1016/j.jep.2011.01.043

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Survey and scientific evaluation of medicinal plants used by the Pahan and Teli tribal communities of Natore district, Bangladesh.

Authors:  Mohammed Rahmatullah; Zubaida Khatun; Abid Hasan; Waheda Parvin; Md Moniruzzaman; Asha Khatun; Mostafi Jumrut Mahal; Md Shaiful Alam Bhuiyan; Sadia Moin Mou; Rownak Jahan
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

2.  In vitro anti-proliferative effects of Zuojinwan on eight kinds of human cancer cell lines.

Authors:  Lina Xu; Yan Qi; Linlin Lv; Youwei Xu; Lingli Zheng; Lianhong Yin; Kexin Liu; Xu Han; Yanyan Zhao; Jinyong Peng
Journal:  Cytotechnology       Date:  2013-02-09       Impact factor: 2.058

3.  Cytotoxic effects of chloroform and hydroalcoholic extracts of aerial parts of Cuscuta chinensis and Cuscuta epithymum on Hela, HT29 and MDA-MB-468 tumor cells.

Authors:  A Jafarian; A Ghannadi; B Mohebi
Journal:  Res Pharm Sci       Date:  2014 Mar-Apr

4.  Cuscuta campestris induces apoptosis by increasing reactive oxygen species generation in human leukemic cells.

Authors:  Maliheh Moradzadeh; Azar Hosseini; Hasan Rakhshandeh; Azita Aghaei; Hamid Reza Sadeghnia
Journal:  Avicenna J Phytomed       Date:  2018 May-Jun

Review 5.  Vascular Epiphytic Medicinal Plants as Sources of Therapeutic Agents: Their Ethnopharmacological Uses, Chemical Composition, and Biological Activities.

Authors:  Ari Satia Nugraha; Bawon Triatmoko; Phurpa Wangchuk; Paul A Keller
Journal:  Biomolecules       Date:  2020-01-24

Review 6.  The genus Cuscuta (Convolvolaceac): An updated review on indigenous uses, phytochemistry, and pharmacology.

Authors:  Shazia Noureen; Sobia Noreen; Shazia Akram Ghumman; Fozia Batool; Syed Nasir Abbas Bukhari
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

7.  Evaluation of the anti-diarrheal effects of the whole plant extracts of Cuscuta reflexa Roxb in pigeons.

Authors:  Naveed Muhammad; Sana Ullah; Abdur Rauf; Muhammad Atif; Seema Patel; Muhammad Israr; Sajid Akbar; Omer Shehzad; Muhammad Saeed; Saud Bawazeer; Md Sahab Uddin; Marina Derkho; Mohammad Ali Shariati; Mohammad S Mubarak
Journal:  Toxicol Rep       Date:  2021-02-23

8.  Korean Red Ginseng Suppresses Metastasis of Human Hepatoma SK-Hep1 Cells by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase Plasminogen Activator.

Authors:  Yu-Ling Ho; Kun-Cheng Li; Wei Chao; Yuan-Shiun Chang; Guan-Jhong Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-17       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.